Sesame Care vs WellMedr

Strengths

• +Real FDA-approved brand-name access — Wegovy pen and pill, Zepbound, Ozempic, Mounjaro and Rybelsus
• +Established platform (operating since 2018) with LegitScript, BBB accreditation and large third-party review volume
• +You choose the provider and see the price up front — genuine marketplace transparency
• +Oral routes available (Wegovy pill, Rybelsus)

Where it loses points

• –A generalist marketplace, not a dedicated weight-loss program — lighter ongoing hand-holding than a specialist desk
• –Two-part cost (a platform subscription plus the medication) makes the true monthly total harder to compare
• –Brand-name cash prices can run high without insurance

Strengths

• +Eight named microdose products across oral and injectable routes, each with its formulation published — a real low-dose line, not a smaller amount of a standard plan
• +States its dose basis outright on the tirzepatide plan: "Same price regardless of dosage"
• +Publishes what a "month" contains — both plans say "shipped every 4 weeks" on the plan card itself
• +Names the treating clinical group in its telehealth consent: OpenLoop Health, Inc. and its state professional corporations
• +Names both halves of the supply chain: OpenLoop Health, Inc. as the medical group and "Mycelium Pharmacy — our U.S.-licensed fulfillment pharmacy" as the dispenser — most compounded sellers name neither
• +Puts the compounding caveat on the pricing page, not in a footer: compounded medications are "regulated by state Boards of Pharmacy, but are not evaluated by the FDA for safety or efficacy", with explicit thyroid C-cell tumor and MTC warnings
• +Offers FDA-approved brand product — Ozempic from $1,399, Zepbound from $1,599 — for anyone who decides against compounded

Where it loses points

• –The microdose page headlines "ZERO Side Effects", subheaded "Zero side effct for 70%+ of members" (their typo) — an unqualified claim no evidence supports, on a page that carries no safety notice at all — the thyroid C-cell tumor warning is on the pricing page, not this one
• –ITS FAQ SAYS THE MEDICATIONS ARE FDA APPROVED. Asked "Are these medications FDA approved?", the page answers "Yes. We only work with U.S. licensed pharmacies that dispense FDA-approved medications" — while the footer of that same page says they are "not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality". A buyer asking the one regulatory question that matters is told the opposite of the truth
• –TWO DIFFERENT BILLING CYCLES ARE PUBLISHED. The plan cards say "shipped every 4 weeks" — 13 charges a year — while the refund policy says the subscription "will automatically renew every 21 days", which is about 17. Which one your card sees is not knowable from the site
• –The advertised $59 is a twelve-month rate — the banner reads "Lock In $200 OFF Every Month, or $59/mo on 12/month Plans — For Life". It names only that figure; the $99 tirzepatide card carries no such condition and says "Cancel or change anytime". Yet no standing month-to-month rate is published for either molecule
• –A "month" is four weeks on both plans, so a year is 13 charges rather than 12 — about 8.6% more than the monthly label implies
• –Six of the eight microdose products publish no price at all; the two that do both show $199/month regardless of formulation
• –The semaglutide plan makes no statement about dose basis in either direction, so whether a low dose costs less there is simply unknown
• –Two discounts stack — "$200 OFF Every Month" and a separate "$150 off for Life" — and neither reverses into a standing rate
• –The results carousel is disclosed as "Inspired by real patient success stories in similar Telehealth programs", so those figures are not WellMedr patients
• –The top bar advertises "FDA-regulated pharmacies" — a claim about the pharmacy, not the drug
• –The pharmacy is named only in the privacy policy — not on the pricing page, the microdose page or anywhere a buyer would look for it